Jupiter Neurosciences
JUNS
10 hedge funds and large institutions have $716K invested in Jupiter Neurosciences in 2026 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 6 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
0.05% more ownership
Funds ownership: 0.02% → 0.07% (+0.05%)
17% less funds holding
Funds holding: 12 → 10 (-2)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
56% less capital invested
Capital invested by funds: $1.64M → $716K (-$925K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VC
Vestor Capital
Chicago,
Illinois
|
+$597K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$62.5K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$48.6K |
| 4 |
VF
Virtu Financial
New York
|
+$8.35K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$2.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACG
Allen Capital Group
Grand Island,
Nebraska
|
-$30.6K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$29.9K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$21.9K |
| 4 |
Jane Street
New York
|
-$14.7K |
| 5 |
Russell Investments Group
London,
United Kingdom
|
-$3.06K |
JUNS Hedge Fund Activity: Q1 2026 in Review
10 of the 8,161 institutional investors tracked by Wall St. Rank reported a position in Jupiter Neurosciences (JUNS) for Q1 2026, worth a combined $716K — down 56% from $1.64M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of JUNS and 5 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 2 added.
The largest buyer was Vestor Capital, adding an estimated $597K. The largest seller was Allen Capital Group, exiting entirely with an estimated $30.6K sold.
- 10 institutional investors held Jupiter Neurosciences (JUNS) as of Q1 2026, down from 12 in Q4 2025.
- Funds reported $716K of Jupiter Neurosciences stock for Q1 2026, down 56% quarter-over-quarter.
- 5 funds opened new Jupiter Neurosciences positions in Q1 2026 and 6 closed out, a net change of -1 holder.
- The largest Jupiter Neurosciences buyer in Q1 2026 was Vestor Capital, an estimated $597K added.
- The largest Jupiter Neurosciences seller in Q1 2026 was Allen Capital Group, an estimated $30.6K sold.
Based on aggregated 13F filings for Q1 2026.